Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 961 | CDT CDT Equity Inc. Common Stock | 4.73 USD | -5.02% | +8.74% | +827.45% | +469.88% | 12.33 K USD | ||
| 962 | GMAB Genmab A/S ADS | 29.04 USD | +2.98% | +5.79% | +10.33% | +47.71% | 0 USD | ||
| 963 | OCS Oculis Holding AG Ordinary shares | 27.59 USD | +1.73% | +5.51% | +7.82% | +57.93% | 0 USD | ||
| 964 | AZN AstraZeneca PLC | 202.93 USD | +0.09% | +1.13% | +6.37% | +197.99% | 0 USD | ||
| 965 | ANL Adlai Nortye Ltd. American Depositary Shares | 14.38 USD | +19.24% | +42.38% | +77.09% | +588.04% | 0 USD | ||
| 966 | GRFS Grifois, S.A. | 8.58 USD | +2.63% | +6.72% | +7.79% | +22.75% | 0 USD | ||
| 967 | NVO Novo-Nordisk A/S | 39.20 USD | +3.29% | +6.26% | +3.24% | -40.29% | 0 USD | ||
| 968 | SXTC China SXT Pharmaceuticals, Inc. Class A Ordinary Shares | 2.34 USD | +0.86% | +15.84% | +19.39% | -6.02% | 0 USD | ||
| 969 | CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0990 USD | -0.90% | +16.33% | -24.77% | +208.41% | 0 USD | ||
| 970 | YDES YD Bio Limited Ordinary Shares | 5.60 USD | -2.44% | -16.79% | -25.63% | -30.00% | 0 USD | ||
| 971 | ADAP Adaptimmune Therapeutics PLC | 0.05 USD | -16.67% | 0.00% | -61.54% | -91.38% | 0 USD | ||
| 972 | AADI Whitehawk Therapeutics, Inc. | 2.05 USD | -2.38% | 0.00% | -19.29% | -27.30% | 0 USD | ||
| 973 | RVMDW Revolution Medicines, Inc. Common Stock | 5.1150 USD | +15.99% | +181.82% | +187.36% | +10150.50% | 28.64 B USD | ||
| 974 | BTSGU BrightSpring Health Services, Inc. Common Stock | 153.9700 USD | +2.43% | +5.16% | +17.05% | +147.94% | 8.92 B USD | ||
| 975 | NAMSW NewAmsterdam Pharma Company N.V. Ordinary Shares | 23.4000 USD | -0.43% | +6.27% | +30.00% | +254.55% | 4.14 B USD | ||
| 976 | SLXNW Silexion Therapeutics Corp Ordinary Shares | 0.0270 USD | +5.88% | +81.21% | +80.00% | -54.77% | 3.50 B USD | ||
| 977 | WGSWW GeneDx Holdings Corp. Class A Common Stock | 0.0077 USD | +4.05% | +2.67% | -6.10% | -95.03% | 1.91 B USD | ||
| 978 | ALVOW Alvotech Ordinary Shares | 0.3100 USD | +34.78% | +23.95% | -18.42% | -79.33% | 1.13 B USD | ||
| 979 | TALKW Talkspace, Inc. Common Stock | 0.0016 USD | -5.88% | -30.43% | -46.67% | -97.87% | 865.45 M USD | ||
| 980 | DRTSW Alpha Tau Medical Ltd. Ordinary Shares | 0.9000 USD | +7.78% | +12.50% | +2.05% | +328.57% | 680.32 M USD |
Notizie Titoli del Settore Sanitario
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today (NYSE:JNJ)
Einhorn dà priorità alla protezione del capitale, avverte sui rischi al ribasso
Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now?
Regeneron Boosts Cancer Pipeline Through Telix Collaboration
MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes
Il titolo Avanos Medical balza per l’acquisizione da $1,27 mld di AIP
Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.
Gainers Titoli del Settore Sanitario
IINNW Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares | 0.1036 | +72.67% |
AVNS Avanos Medical, Inc. | 24.67 | +70.37% |
EUDAW EUDA Health Holdings Limited Ordinary Shares | 0.0345 | +48.07% |
HOTH Hoth Therapeutics, Inc. Common Stock | 0.72 | +41.18% |
TVTX Travere Therapeutics, Inc. Common Stock | 41.5500 | +35.34% |
TOIIW The Oncology Institute, Inc. Common Stock | 0.0489 | +28.68% |
SCLXW Scilex Holding Company Common Stock | 0.1039 | +22.81% |
PIIIW P3 Health Partners Inc. Common Stock | 0.0053 | +20.45% |
Losers Titoli del Settore Sanitario
CMND Clearmind Medicine Inc. Common Shares | 0.88 | -38.46% |
WORX SC WORX Corp | 1.06 | -30.72% |
CINGW Cingulate Inc. Common Stock | 0.0200 | -20.63% |
JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
ALLO Allogene Therapeutics, Inc. Common Stock | 2.51 | -17.97% |
VRAX Virax Biolabs Group Limited Ordinary Shares | 0.14 | -17.65% |
NRXPW NRX Pharmaceuticals, Inc. Common Stock | 0.0100 | -16.67% |
PHGE BiomX Inc. | 2.2000 | -15.71% |